GLPwatch
Iixisenatide. Wait for conclusive results on complications of diabetes.
Prescrire Int · 2014
Last updated 2026-05-28A review found no clear evidence that the diabetes drug lixisenatide prevents diabetes-related health complications. Due to potential serious side effects, the risks may outweigh any benefits.
AI summary of the abstract below.
| Journal | Prescrire Int, 2014 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
There is no firm evidence that lixisenatide prevents the clinical complications of diabetes. Given the many potentially serious adverse effects of incretin analogues of this type, the lack of benefit skews the balance towards greater harm.
Verbatim abstract via PubMed 25964965 ↗